Chamomile tea has been consumed for centuries for its purported anti-inflammatory and antioxidant properties, leading many to explore its potential chamomile tea benefits for fatty liver disease. Fatty liver disease, or hepatic steatosis, affects approximately one in three UK adults and occurs when excess fat accumulates in liver cells. Whilst laboratory studies suggest chamomile's bioactive compounds may offer hepatoprotective effects, robust clinical evidence specifically for fatty liver remains limited. Chamomile is not licensed or recommended by NICE, BASL, or the MHRA for treating fatty liver disease. This article examines the current evidence, safe consumption practices, and the essential role of proven lifestyle modifications in managing this increasingly common condition.
Summary: Chamomile tea contains antioxidant and anti-inflammatory compounds studied in laboratory settings, but robust clinical evidence supporting its use specifically for fatty liver disease is lacking, and it is not recommended by UK medical authorities as a treatment.
- Chamomile contains flavonoids (apigenin, quercetin) and terpenoids with antioxidant properties demonstrated in laboratory and animal studies.
- Most evidence derives from experimental models; high-quality human trials examining chamomile's effects on fatty liver disease are notably absent.
- NICE, BASL, and the MHRA do not recommend chamomile for treating non-alcoholic fatty liver disease (NAFLD/MASLD).
- Chamomile may interact with anticoagulants, sedatives, and certain medications; patients should consult their GP before regular use.
- Evidence-based management of fatty liver centres on weight loss (5–10%), dietary modification, physical activity, and addressing metabolic conditions.
- Patients with high-risk fibrosis scores (FIB-4 or ELF test) or persistently elevated liver enzymes require hepatology referral.
Table of Contents
Am I eligible for weight loss injections?
Find out whether you might be eligible!
Answer a few quick questions to see whether you may be suitable for prescription weight loss injections (like Wegovy® or Mounjaro®).
- No commitment — just a quick suitability check
- Takes about 1 minute to complete
Understanding Fatty Liver Disease and Herbal Remedies
Fatty liver disease, medically termed hepatic steatosis, occurs when fat accumulates in more than 5% of liver cells (hepatocytes), typically confirmed by histology or characteristic imaging features. This condition exists in two primary forms: non-alcoholic fatty liver disease (NAFLD)—recently also termed metabolic dysfunction-associated steatotic liver disease (MASLD) by international societies—which affects individuals who consume little to no alcohol, and alcohol-related liver disease (ARLD), directly linked to excessive alcohol intake. NAFLD/MASLD has become increasingly prevalent in the UK, affecting approximately one in three adults according to NHS and British Liver Trust data, often associated with obesity, type 2 diabetes, and metabolic syndrome.
The liver performs over 500 vital functions, including detoxification, protein synthesis, and metabolic regulation. When fat accumulates, it can trigger inflammation, potentially progressing to non-alcoholic steatohepatitis (NASH)—now also termed metabolic dysfunction-associated steatohepatitis (MASH)—fibrosis, and ultimately cirrhosis if left unmanaged. Early-stage fatty liver disease typically presents without symptoms, making it a silent condition often discovered incidentally through blood tests or imaging.
Many individuals explore complementary approaches alongside conventional treatment, with herbal remedies gaining attention for potential hepatoprotective properties. Chamomile tea (Matricaria chamomilla or Chamaemelum nobile) has been consumed for centuries across various cultures for its purported anti-inflammatory and antioxidant effects. Whilst herbal remedies should never replace evidence-based medical treatment, understanding their potential role within a comprehensive management strategy is valuable.
It is essential to recognise that chamomile is not licensed or indicated for the treatment of fatty liver disease in the UK. Regulatory bodies such as NICE, the British Association for the Study of the Liver (BASL), and the MHRA do not recommend chamomile for NAFLD/MASLD. The European Medicines Agency (EMA) recognises chamomile only for traditional use in mild digestive complaints and minor inflammation, not for hepatic conditions. Most chamomile teas are sold as foods, not licensed medicines; if choosing a medicinal chamomile product, look for the Traditional Herbal Registration (THR) symbol indicating regulatory approval for traditional use. Patients considering herbal supplements should always consult their GP or hepatologist, particularly when taking prescribed medications, as herb-drug interactions may occur.
Chamomile Tea: Active Compounds and Liver Health Properties
Chamomile contains numerous bioactive compounds that contribute to its pharmacological profile. The primary constituents include flavonoids (particularly apigenin, quercetin, and luteolin), terpenoids (such as bisabolol and chamazulene), coumarins, and phenolic acids. These phytochemicals exhibit various biological activities that researchers have investigated for potential hepatoprotective mechanisms, though it is important to note that most evidence derives from laboratory (in vitro) and animal studies, and may not translate directly to human tea consumption.
Apigenin, the most abundant flavonoid in chamomile, demonstrates antioxidant properties in experimental models by scavenging free radicals and reducing oxidative stress—a key pathological mechanism in fatty liver disease progression. Laboratory studies suggest apigenin may modulate inflammatory pathways by inhibiting pro-inflammatory cytokines such as tumour necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6), which play significant roles in hepatic inflammation. Additionally, this compound appears to influence lipid metabolism in preclinical models through activation of AMP-activated protein kinase (AMPK), an enzyme that regulates cellular energy balance and fat oxidation.
Chamazulene, formed during essential oil distillation, possesses anti-inflammatory properties in experimental settings. However, it is important to understand that chamazulene is primarily present in chamomile essential oil; standard brewed tea contains much lower and variable amounts. The terpenoid α-bisabolol has shown potential in reducing liver enzyme elevations in experimental models, suggesting a protective effect against hepatocellular injury in laboratory conditions.
The antioxidant capacity of chamomile compounds observed in research is particularly relevant to fatty liver disease, as oxidative stress contributes to the transition from simple steatosis to NASH/MASH. By neutralising reactive oxygen species (ROS) in experimental systems, these compounds may theoretically help prevent lipid peroxidation and subsequent cellular damage. However, it is crucial to emphasise that the bioavailability and therapeutic concentrations achievable through tea consumption remain uncertain compared to concentrated extracts used in research settings. Furthermore, the composition and dose of bioactive compounds vary widely between different chamomile products and preparations, affecting the relevance of laboratory findings to everyday tea drinking. High-quality human clinical trials specifically examining chamomile's effects on fatty liver disease are notably lacking.
Evidence for Chamomile Tea Benefits in Fatty Liver
The scientific evidence supporting chamomile tea specifically for fatty liver disease remains limited and preliminary. Whilst several studies have explored chamomile's hepatoprotective potential in experimental settings, robust clinical trials in humans with diagnosed NAFLD/MASLD are notably scarce. Most existing research comprises animal models, laboratory (in vitro) studies, or investigations into general liver health rather than fatty liver disease specifically. NICE, BASL, and the European Association for the Study of the Liver (EASL) do not recommend chamomile for the treatment of NAFLD/MASLD.
Animal studies have demonstrated promising results in experimental models. Research published in various pharmacology journals has shown that chamomile extracts may reduce hepatic steatosis, lower liver enzyme levels (ALT and AST), and decrease inflammatory markers in rodent models of diet-induced fatty liver disease. One study found that chamomile extract administration reduced hepatic triglyceride accumulation and improved antioxidant enzyme activity in mice fed a high-fat diet. However, translating these findings to human clinical practice requires considerable caution, as animal models do not always predict human responses accurately, and the doses used in research often far exceed those achievable through tea consumption.
A small number of human studies have examined chamomile's effects on metabolic parameters relevant to fatty liver disease. Some research suggests chamomile consumption may modestly improve glycaemic control and lipid profiles in individuals with type 2 diabetes—conditions frequently associated with NAFLD/MASLD. However, these studies did not specifically assess liver fat content or use imaging techniques to confirm hepatic improvements.
The European Medicines Agency's Committee on Herbal Medicinal Products (EMA/HMPC) Community herbal monograph on Matricaria recutita (chamomile) flower recognises chamomile for traditional use in symptomatic treatment of minor gastrointestinal complaints and mild inflammation, but does not list hepatic steatosis or fatty liver disease as an approved indication.
Patients should understand that whilst chamomile tea may be enjoyed as a beverage, it cannot replace evidence-based interventions such as weight loss, dietary modification, and management of underlying metabolic conditions. Anyone considering chamomile or other herbal remedies for liver health should discuss this with their healthcare provider, particularly if they have confirmed liver disease or take medications metabolised by the liver.
How to Use Chamomile Tea Safely for Liver Support
For individuals wishing to incorporate chamomile tea as part of a broader healthy lifestyle approach, understanding safe consumption practices is essential. Chamomile tea is generally considered safe when consumed in typical beverage amounts (1–4 cups daily) by most adults. However, several important safety considerations warrant attention.
Preparation and dosage: Use one to two teaspoons of dried chamomile flowers or one commercial tea bag per cup (approximately 240ml) of boiling water. Steep for 5–10 minutes to allow adequate extraction of bioactive compounds. Whilst there is no established therapeutic dose for liver health specifically, traditional use typically involves 2–3 cups daily. Consuming excessive amounts does not necessarily confer additional benefits and may increase the risk of adverse effects.
Potential interactions and contraindications: Chamomile may interact with certain medications. It possesses mild anticoagulant properties and could theoretically enhance the effects of warfarin or other blood-thinning medications, increasing bleeding risk, though clinical evidence of significant interaction is limited. Individuals taking antiplatelet drugs, anticoagulants, or scheduled for surgery should consult their GP or pharmacist before regular chamomile consumption. Chamomile may also cause drowsiness and could have additive sedative effects when taken with benzodiazepines, sedating antihistamines, or alcohol; caution is advised. Theoretical interactions with medications metabolised by cytochrome P450 enzymes have been suggested, but clinical significance is uncertain; patients taking multiple medications should check with their pharmacist or GP.
Allergic reactions can occur, particularly in individuals with known sensitivities to plants in the Asteraceae/Compositae family (including ragweed, chrysanthemums, marigolds, and daisies). Symptoms may range from mild skin reactions to, rarely, anaphylaxis. Discontinue use immediately if allergic symptoms develop.
Pregnancy and breastfeeding: According to NHS advice, small amounts of chamomile tea are likely acceptable during pregnancy and breastfeeding, but high-dose extracts should be avoided. Pregnant or breastfeeding women should consult their midwife or GP before regular use, as some evidence suggests potential uterine stimulant effects with concentrated preparations.
Reporting side effects: If you experience a suspected side effect from chamomile or any herbal product, report it via the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk or through the Yellow Card app.
When to seek medical advice: Chamomile tea should never delay or replace medical evaluation for liver disease. Contact your GP if you experience:
-
Persistent abdominal pain or swelling
-
Jaundice (yellowing of skin or eyes)
-
Dark urine or pale stools
-
Unexplained fatigue or weight loss
Seek emergency care (call 999 or attend A&E) if you develop:
-
Vomiting blood or passing black, tarry stools
-
Acute confusion or disorientation
-
Severe jaundice with confusion or drowsiness
-
Rapidly worsening abdominal swelling (ascites)
Patients with diagnosed liver disease should work closely with hepatology services and not self-treat with herbal remedies without professional guidance.
Lifestyle Changes and Medical Treatment for Fatty Liver
Evidence-based management of fatty liver disease centres on addressing underlying metabolic risk factors and implementing sustainable lifestyle modifications. According to NICE guidance (NG49), weight loss remains the cornerstone of NAFLD/MASLD treatment. Weight loss of at least 5% of body weight can improve hepatic steatosis, whilst 7–10% weight loss may improve NASH/MASH and fibrosis in some patients. Gradual weight reduction of 0.5–1kg per week is recommended.
Dietary interventions should focus on:
-
Caloric restriction to achieve gradual, sustainable weight loss
-
Mediterranean-style diet rich in vegetables, fruits, whole grains, legumes, nuts, and olive oil
-
Reducing refined carbohydrates and added sugars, particularly fructose-containing beverages
-
Limiting saturated fats whilst incorporating omega-3 fatty acids from oily fish
-
Moderating portion sizes and avoiding late-night eating
Physical activity plays a crucial role independent of weight loss. The UK Chief Medical Officers recommend at least 150 minutes of moderate-intensity aerobic exercise weekly for adults, combined with resistance training on two or more days per week. Regular physical activity improves insulin sensitivity, reduces hepatic fat content, and decreases inflammatory markers even without significant weight reduction.
Alcohol consumption: Patients should keep within UK Chief Medical Officers' low-risk drinking guidelines: no more than 14 units per week, spread over at least three days, with several alcohol-free days. Patients with advanced fibrosis, cirrhosis, or alcohol-related liver disease should be strongly advised to abstain completely. Even moderate alcohol consumption may accelerate liver disease progression in those with existing hepatic steatosis.
Medical management addresses associated conditions:
-
Type 2 diabetes control: Optimising glycaemic management with metformin as first-line therapy per NICE guidance; newer agents like GLP-1 receptor agonists and SGLT2 inhibitors are used for diabetes management and may have beneficial effects on liver outcomes, though they are not licensed specifically for NAFLD/MASLD treatment
-
Dyslipidaemia treatment: Statins are safe in stable liver disease and reduce cardiovascular risk
-
Hypertension management: Standard antihypertensive therapy as per NICE guidelines
Pharmacological treatments specifically for NASH/MASH remain limited. Pioglitazone and vitamin E have shown benefits in selected patients with biopsy-proven NASH, though their use requires specialist hepatology input. Several novel therapies are under investigation in clinical trials.
Risk stratification and monitoring: NICE recommends using age-specific FIB-4 score thresholds to assess fibrosis risk:
-
Under 65 years: FIB-4 <1.3 indicates low risk; >2.67 indicates high risk
-
65 years and over: FIB-4 <2.0 indicates low risk; higher thresholds apply
For patients with indeterminate or high FIB-4 scores, Enhanced Liver Fibrosis (ELF) blood test should be considered as per NICE diagnostic guidance (DG34). An ELF score of 10.51 or above suggests advanced fibrosis and warrants hepatology referral. Routine ultrasound is not recommended for monitoring disease progression; non-invasive fibrosis markers are preferred.
Regular monitoring should include:
-
Liver function tests (ALT, AST, GGT, bilirubin, albumin, platelet count)
-
Metabolic parameters (HbA1c, lipid profile)
-
Non-invasive fibrosis assessment (age-specific FIB-4 score, ELF test where indicated)
Referral to hepatology is indicated for:
-
High-risk FIB-4 or ELF score suggesting advanced fibrosis (local pathways may vary)
-
Persistently elevated liver enzymes (>6 months) despite lifestyle modification
-
Uncertainty about diagnosis or presence of other liver conditions
-
Clinical concern or features of decompensated liver disease
-
Consideration for clinical trials
Patients should understand that fatty liver disease is largely reversible with appropriate intervention, particularly when detected early. Whilst complementary approaches like chamomile tea may form part of a holistic wellness strategy, they cannot substitute for proven lifestyle modifications and medical management. A collaborative approach involving primary care, specialist services when needed, and patient commitment to sustainable behaviour change offers the best outcomes for liver health and overall metabolic wellbeing.
Key resources:
-
NICE NG49: Non-alcoholic fatty liver disease: assessment and management
-
NICE DG34: ELF test to identify advanced liver fibrosis in adults with NAFLD
-
NHS and British Liver Trust patient information on NAFLD/MASLD
-
UK Chief Medical Officers' low-risk drinking guidelines
-
MHRA Yellow Card Scheme for reporting suspected side effects
Frequently Asked Questions
Can drinking chamomile tea actually help reduce fat in my liver?
Whilst laboratory studies show chamomile's antioxidant compounds may protect liver cells in experimental settings, there is insufficient clinical evidence to confirm that drinking chamomile tea reduces liver fat in humans. Evidence-based treatments for fatty liver disease focus on weight loss, dietary changes, and physical activity, which have proven effectiveness.
How much chamomile tea should I drink daily for liver health?
Chamomile tea is generally safe at typical beverage amounts of 1–4 cups daily, though no therapeutic dose for liver health has been established. Traditional use suggests 2–3 cups daily, but chamomile should complement, not replace, proven lifestyle modifications and medical treatment for fatty liver disease.
Is chamomile tea safe to drink if I'm taking medication for diabetes or high cholesterol?
Chamomile may interact with certain medications, including anticoagulants and sedatives, though interactions with diabetes or cholesterol medications are less well documented. Always consult your GP or pharmacist before regularly consuming chamomile tea if you take prescribed medications, particularly multiple drugs.
What's the difference between chamomile tea and other herbal remedies for fatty liver?
Various herbal remedies claim liver benefits, but none are licensed or recommended by UK medical authorities for treating fatty liver disease. Chamomile contains flavonoids and terpenoids with antioxidant properties, whilst other herbs like milk thistle contain different compounds, but all lack robust clinical evidence for fatty liver treatment in humans.
Can I use chamomile tea instead of losing weight to treat my fatty liver?
No, chamomile tea cannot replace evidence-based treatments for fatty liver disease. According to NICE guidance, weight loss of 5–10% of body weight, combined with dietary modification and regular physical activity, remains the cornerstone of effective fatty liver management with proven clinical benefits.
When should I see my GP about fatty liver instead of trying chamomile tea?
Contact your GP if you experience persistent abdominal pain, jaundice (yellowing of skin or eyes), dark urine, unexplained fatigue, or have persistently elevated liver enzymes for more than six months. Chamomile tea should never delay medical evaluation, and patients with diagnosed liver disease require professional monitoring and evidence-based treatment.
The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.
The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Heading 6
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Block quote
Ordered list
- Item 1
- Item 2
- Item 3
Unordered list
- Item A
- Item B
- Item C
Bold text
Emphasis
Superscript
Subscript
